NCT07032103View on ClinicalTrials.gov

Prospective Cohort Study for Lymphoma: Samsung Lymphoma Cohort Study IV

RecruitingOBSERVATIONAL

Enrollment

2,000

Participants

Timeline

Start Date

June 1, 2022

Primary Completion Date

December 30, 2028

Study Completion Date

December 30, 2028

Conditions

Lymphoma

Interventions

DRUG

Immunochemotherapy

Systemic chemotherapy with curative intent

Trial Locations (1)

06351

RECRUITING

Samsung Medical Center, Seoul

All Listed Sponsors

lead

Samsung Medical Center

OTHER